The DOI matches its Crossref record; 119 of the 121 references it cites were found in a registry or an index.
Biochemical Verification of Tobacco Use and Abstinence: 2019 Update
Open accessAbstract
BACKGROUND: The changing prevalence and patterns of tobacco use, the advent of novel nicotine delivery devices, and the development of new biomarkers prompted an update of the 2002 Society for Research on Nicotine and Tobacco (SRNT) report on whether and how to apply biomarker verification for tobacco use and abstinence. METHODS: The SRNT Treatment Research Network convened a group of investigators with expertise in tobacco biomarkers to update the recommendations of the 2002 SNRT Biochemical Verification Report. RESULTS: Biochemical verification of tobacco use and abstinence increases scientific rigor and is recommended in clinical trials of smoking cessation, when feasible. Sources, appropriate biospecimens, cutpoints, time of detection windows and analytic methods for carbon monoxide, cotinine (including over the counter tests), total nicotine equivalents, minor tobacco alkaloids, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol are reviewed, as well as biochemical approaches to distinguishing cigarette smoking from use of electronic nicotine delivery devices (ENDS). CONCLUSIONS: Recommendations are provided for whether and how to use biochemical verification of tobacco use and abstinence. Guidelines are provided on which biomarkers to use, which biospecimens to use, optimal cutpoints, time windows to detection, and methodology for biochemical verifications. Use of combinations of biomarkers is recommended for assessment of ENDS use. IMPLICATIONS: Biochemical verification increases scientific rigor, but there are drawbacks that need to be assessed to determine whether the benefits of biochemical verification outweigh the costs, including the cost of the assays, the feasibility of sample collection, the ability to draw clear conclusions based on the duration of abstinence, and the variability of the assay within the study population. This paper provides updated recommendations from the 2002 SRNT report on whether and how to use biochemical markers in determining tobacco use and abstinence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“authors like Benowitz et al. (2020) and West et al. (2005) suggest that abstinence outcomes are also reliable in those studies in which biochemical verification is not feasible, such as those in which the data are collected by phone or through the internet or when personal contact is limited.”
From Evaluation of effectiveness and acceptability of a psychological treatment for smoking cessation combined with a smartphone App: A pilot study (2024) · cites this paper as Benowitz et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,766
Current Cigarette Smoking Among Adults — United States, 2005–2014
Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S., & King, B. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 2,544
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Self-citationThe validity of self-reported smoking: a review and meta-analysis.
Patrick, D. L., Cheadle, A. D., Thompson, D. C., Diehr, P. H., Koepsell, T. D., & Kinne, S. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.7.1086 · Cited by 1,737
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,583
Self-citationAnthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Self-citationBiochemistry, Biology, and Carcinogenicity of Tobacco-Specific N -Nitrosamines
Hecht, S. S. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980005y · Cited by 1,074
Self-citationComparison of tests used to distinguish smokers from nonsmokers
Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.11.1435 · Cited by 994
Self-citationCurrent Cigarette Smoking Among Adults — United States, 2005–2015
Jamal, A., King, B. A., Neff, L. J., Whitmill, J., Babb, S. D., & Graffunder, C. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544a2 · Cited by 920
Benowitz, N. L., Bernert, J. T., Caraballo, R. S., Holiday, D. B., & Wang, J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn301 · Cited by 684
Self-citation
Research works printed but not linked: 1
- International Agency for Research on Cancer., 2007, Smokeless tobacco and tobacco-specific nitrosamines, 41
Cited by
Sorted by citations
Items 501–600 of 621
Williams, P. P., Huddlestone, L., Shoesmith, E., Brady, S., Mitchell, A. S., Exley, V., Wiggins, F., Sinclair, L., Pervin, J., Horspool, M. J., et al. (2024) · medRxiv · doi:10.1101/2024.10.31.24316412
Cook, B. L., Flores, M. W., Progovac, A. M., Moyer, M., Holmes, K. E., Le, T. P., Kumar, A., Levy, D. E., Saloner, B. K., & Wayne, G. F. (2024) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2024.11.010
Gupte, H., & Mandal, G. (2024) · Population Medicine · doi:10.18332/popmed/195851
Ramirez, G. F., Badii, N., Mohn, P., Northrup, A., Smoot, C. B., Doran, N., Brouwer, K. C., Myers, M. G., Godino, J., Liu, J., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-20997-6
Kshtriya, P., Goel, S., & Ghosh, A. (2024) · Public Health in Practice · doi:10.1016/j.puhip.2024.100581
Essentials: Preoperative Optimization for Bariatric Surgery
Grille, V. J., & Rogers, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-72309-4_11
Cotinine Testing as a Component of Screening for Tobacco use in a Pediatric Hospital
Schmuhl, K. K., Golec, A. S., Bonny, A. E., Manos, B. E., Merianos, A. L., Stull, S. W., & Ebersole, A. M. (2025) · Health Behavior Research · doi:10.4148/2572-1836.1284
“Specifically, cotinine is a widely used nicotine metabolite that can be measured in patients’ urine to determine nicotine exposure and has a half-life of about 16 hours (Benowitz et al., 2020).”
Park, Y., Park, H., Lee, J. H., Lee, J. H., Cho, S., & Choi, Y. S. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.108846
Rodríguez-Bolaños, R., Ramírez‐Palacios, P., Gallegos-Carrillo, K., Chávez‐Iñiguez, A., Lara, D., Ossip, D. J., Cupertino, A. P., & Cartujano‐Barrera, F. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00752-2
Evaluating Outcomes in Septorhinoplasty Procedures Using Serum Cotinine as a Measure for Tobacco Use
Chan, K., Patel, S. D., Keane, A., King, T. S., & Lighthall, J. G. (2025) · Otolaryngology · doi:10.1002/ohn.1212
“…ranging from 1 to 10 ng/mL. 16,17 On average, serum cotinine levels in active smokers can range from 250 to 300 ng/mL and sometimes >500 ng/mL. 18,19 The purpose of this study is to use serum cotinine levels to evaluate the effects of tobacco consumption on complication rates and functional…”
Urquhart, S. B., Webb, G. I., Leong, S., & Webb, A. R. (2025) · Anaesthesia and Intensive Care · doi:10.1177/0310057x251315764
“8 22–24 The repercussion of this is that omitting bioverification from studies may not bias results.”
Fukuda, T., Kyozuka, H., Murata, T., Yasuda, S., Yamaguchi, A., Satô, A., Ogata, Y., Hosoya, M., Yasumura, S., Hashimoto, K., et al. (2025) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2025.2497059
“To date, only one study has been conducted on the association of serum cotinine with placental abruption [14].”
Keke, C., Lebina, L., Motlhaoleng, K., NIAURA, R. S., Abrams, D. B., Variava, E., Gupte, N., Golub, J. E., Martinson, N. A., & Elf, J. L. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22071040
“Further, marijuana use was highly prevalent in our sample, and smoking marijuana produces CO levels similar to tobacco smoking, which may have limited our ability to measure smoking status correctly [51].”
Tang, M. K., Carmella, S. G., Zhao, Y., Maertens, L. A., Pimentel, L. G., Hatsukami, D. K., & Hecht, S. S. (2025) · Journal of Chromatography B · doi:10.1016/j.jchromb.2025.124719
Self-citationYi, Y.-S., Kim, H. J., Bae, E. J., Lee, Y. I., Lee, C. M., Shim, S. H., Kim, M., & Lim, M. H. (2025) · Psychiatry International · doi:10.3390/psychiatryint6030081
Cheney, M. K., Zingg, T., Kezbers, K. M., Montgomery, A., Bain, C. M., Stanley, N., Frank-Pearce, S. G., Kendzor, D. E., Hébert, E. T., & Businelle, M. S. (2025) · American Journal of Health Promotion · doi:10.1177/08901171251361470
El‐Toukhy, S., Haghayegh, S., Leavens, E. L. S., Sassano, F., & Tarran, R. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103292
“…a <10 parts per million (ppm) exhaled CO reading obtained during the in-person screening and retrospectively by absence of nicotine in blood sample 64 65 ; willing to abstain from using any nicotine products or devices for ≥ 12 hours prior to the lab visit; willing to abstain from alcohol use for…”
Park, S. M. (2025) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2025.5.e15
Secades‐Villa, R., Cuesta‐López, I., & González‐Roz, A. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112893
E-cigarette puff topography instruction to enhance switching among COPD patients who smoke
Leavens, E. L. S., Wagener, T. L., Lambart, L., Mayo, M. S., Brown, L., Ellerbeck, E. F., Billinger, S. A., Comfort, B. W., Woodward, J. M., Sear, B., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1664400
Ramos-Carro, M., Martínez-Vispo, C., López‐Durán, A., & Becoña, E. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251370820
“18,35,36 Moreover, to gain confidence in self-reported data, we compared cessation percentages between those participants with biochemical validation and those with only self-reported data, finding no significant group differences ( χ 2 = 1.97, P = .160).”
InfluentialPerceived Health Concerns of Child Hand Nicotine Levels Among Parental Smokers of Young Children
Mahabee‐Gittens, E. M., Matt, G. E., Stone, L., Hill, M. J., & Merianos, A. L. (2025) · Hospital Pediatrics · doi:10.1542/hpeds.2025-008374
Tobacco Smoke Exposure Biomarker Profiles and Healthcare Utilization Patterns Among U.S. Children
Merianos, A. L., Matt, G. E., Jandarov, R., & Mahabee‐Gittens, E. M. (2025) · Toxics · doi:10.3390/toxics13110909
“Furthermore, children without current asthma who had higher TNE2 levels, a more stable measure of daily nicotine intake than cotinine [14], had a higher risk of frequent healthcare visits.”
InfluentialPetersen, A. B., Rosas, B., Belliard, J. C., Tsoh, J. Y., Oshiro, B. T., Yao, R., & Singh, P. N. (2025) · medRxiv · doi:10.1101/2025.10.26.25338756
Zylva, R. D., Wilson, C. J., & Ward, P. (2025) · Journal of Health Psychology · doi:10.1177/13591053251371955
“We defined cessation as not having inhaled any tobacco for at least 1 week or where biomarkers return to (or close to) the levels of a non-smoker, as defined by Benowitz et al. (2020) in their update of biochemical verification guidelines.”
Training a Smoking Status Probabilistic Model Using Cotinine Levels in a Large Claims Database
Medaglio, D., Leonard, C. E., Shields, A. J. S., Schnoll, R. A., & Gross, R. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf222
Drobes, D. J., Sutton, S. K., Conn, M. R., Brandon, T. H., Yang, M.-J., Sawyer, L. E., Hatsukami, D. K., Donny, E. C., & Simmons, V. N. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112971
Malpeddi, T., Poongulali, S., Shuter, J., Rigotti, N. A., An, L. C., Kumarasamy, N., Reddy, K. P., Shergina, E., Colborn, K. L., Faith, B., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108179
Ramos-Carro, M., Rodríguez‐Cano, R., Martínez-Vispo, C., López‐Durán, A., & Becoña, E. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.113004
Ussher, M., Best, C., Lewis, S., McKell, J., Coleman, T., Cooper, S., Orton, S., & Bauld, L. (2021) · Figshare · doi:10.6084/m9.figshare.15094882
La, R., Zhou, L., Yin, Y., Lu, L., Li, L., Jiang, D., Huang, L., & Wu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.25558975
Adkins-Hempel, M., Japuntich, S. J., Chrastek, M., DUNSIGER, S. I., Breault, C., Ayenew, W., Everson‐Rose, S. A., Nijjar, P. S., Bock, B. C., Wu, W.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26589072
Zylva, R. D., Mortimer, E. K., Miller, E. R., Tsourtos, G., Lawn, S., Wilson, C., Karnon, J., Woodman, R. J., & Ward, P. (2024) · Figshare · doi:10.6084/m9.figshare.26566634
La, R., Zhou, L., Yin, Y., Lu, L., Li, L., Jiang, D., Huang, L., & Wu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.25558927
Huang, S., Tang, O., Zheng, X., Li, H., Wu, Y., & Yang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26593790
Zylva, R. D., Mortimer, E. K., Miller, E. R., Tsourtos, G., Lawn, S., Wilson, C., Karnon, J., Woodman, R. J., & Ward, P. (2024) · Figshare · doi:10.6084/m9.figshare.26566631
Cummings, K. M., Talbot, V., Roberson, A., Bliss, A. A., Likins, E., Brownstein, N. C., Stansell, S., Adams-Ludd, D., Harris, B., Louder, D. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26735331
Adkins-Hempel, M., Japuntich, S. J., Chrastek, M., DUNSIGER, S. I., Breault, C., Ayenew, W., Everson‐Rose, S. A., Nijjar, P. S., Bock, B. C., Wu, W.-C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26589075
Kim, H.-J., Phung, K., Taylor, K., Orton, A., McCormick, S., Chappell, A., & Pilkington, L. I. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.181223
Fromme, H. (2026) · Springer eBooks · doi:10.1007/978-3-032-06538-4_7
Gallegos-Carrillo, K., Ramírez‐Palacios, P., Chávez‐Iñiguez, A., Cupertino, A. P., Cartujano‐Barrera, F., & Rodríguez-Bolaños, R. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/213755 · Cited by 1
“Biochemical verification was conducted among those reporting abstinence: a urine cotinine test (<50 ng/mL = confirmed abstinence) 23,24 .”
López‐Durán, A., Martínez-Vispo, C., Suárez-Castro, D., Barroso-Hurtado, M., Míguez, M. C., & Becoña, E. (2026) · Current Psychology · doi:10.1007/s12144-025-08818-4
“Nevertheless, self-reported smoking status is considered a satisfactory tool when a study is conducted in healthy individuals, and biochemical confirmation is not feasible (Benowitz et al., 2020; Pell et al., 2008 ).”
Arístegui, I., Panizoni, E., Mejía, R. M., Ai, L. P., Caballero, R., Zeltman, A., Cardozo, N. F., Fabian, S., Herrera, B., Dorado, N., et al. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag012
Schönenberger, C., Berthet, A., Briel, M., Amstutz, A., Cavassini, M. L., Sartori, L., Rime, C., Staedler, D., & Lucarini, F. (2026) · Journal of Chromatography B · doi:10.1016/j.jchromb.2026.124942
Tsyvian, A., Beema, A. N., Naksho, A., Chammas, J.-B., Gigliotti, J., Samim, F., Makhoul, N. M., & Janati, A. I. (2026) · BMC Oral Health · doi:10.1186/s12903-026-07820-x
Dabur, D., Li, J., Rana, P., & Wu, H. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05171
Poongulali, S., Rigotti, N. A., Kumarasamy, N., Nagawa, C. S., Faith, B., & Kruse, G. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-42986-y
Chabuk, H. A.-H., & Mohammed, W. J. (2026) · Scientifica · doi:10.1155/sci5/1214459
Food insecurity and elevated nicotine exposure among U.S. tobacco users: Evidence from NHANES
Roulette, C. J. (2026) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2026.100689
Lemos, R. F., Williams, J., Tegge, A. N., Bovo, A. C. D. L., Kaur, R. P., Stein, J. S., Smith, T. T., Cummings, M. K., & Bickel, W. K. (2026) · Tobacco Control · doi:10.1136/tc-2025-059752
“…month; (3) provided a breath carbon monoxide (CO) sample measuring ≥6 ppm, consistent with biochemical verification of current cigarette smoking 15 16 ; (4) did not use e-cigarettes regularly, defined as no more than 9 days of e-cigarette use in the past 30 days, to ensure the sample consisted…”
Newborn metabolomic perturbations associated with prenatal tobacco smoke exposure and early birth
Nesbeth, P.-D. C., Lyu, X., Dunlop, A. W., Tan, Y., Barr, D. B., Yakimavets, V., Panuwet, P., Ren, M., Eick, S. M., Rushing, B. R., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01534-5
Ajayi, A. A., Adkins-Hempel, M., Breault, C., Ayenew, W., Everson‐Rose, S. A., Japuntich, S. J., DUNSIGER, S. I., & Busch, A. M. (2026) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-026-02940-0
CNDP1 (CTG)5 allele and cardiovascular events in high-risk patients: LURIC study results
Hettler, S. A., Moissl, A. P., Delgado, G. E., Skladny, H., März, W., Kramer, B., Yard, B. A., & Kleber, M. E. (2026) · Scientific Reports · doi:10.1038/s41598-026-49233-4
“Genotyping was performed using standard PCR protocols using a fluorescence-labeled forward primer (”
Chung, C., Chang, C.-H., Chang, C.-H., Chang, W.-C., Chang, Y., Hsiao, P., Lien, C., Chang, H., Chung, M., & Chung, C. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128196
Ramos-Carro, M., Martínez-Vispo, C., López‐Durán, A., & Becoña, E. (2026) · Addictive Behaviors · doi:10.1016/j.addbeh.2026.108729
Varyvoda, T., Zolotarova, T., Moiz, A., Munteanu, D., Filion, K. B., & Eisenberg, M. J. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.01.051
Nicotine-Mediated Redox and Nitrosative Stress in Cardiorenal Health
Semenikhina, M., Jones, A., Pasham, V., Budisavljevic, M. N., Palygin, O., & Ilatovskaya, D. V. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26095
Biochemical verification of tobacco use in ICU patients using point-of-care urinary cotinine
Surace, S. J., Presneill, J., Ankravs, M. J., Panganiban, H. P., Moore, C., Barrese, A., Deane, A. M., & Plummer, M. P. (2026) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2026.100185
Poudel, K. C., Silwal, R. C., Chalise, B. S., Shrestha, R., & Poudel‐Tandukar, K. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2671344
“…verification increases scientific rigor, self-report of tobacco use can be considered an acceptable standard in cessation trials and clinical practice, given the cost, feasibility of sample collection, and ability to draw clear conclusions from abstinence duration (Benowitz et al., 2020).”
Goerigk, S. A., Burkhardt, G., Padberg, F., Zeren, A., Ludwig, H., Rabenstein, A., Kröger, C. B., Vragolic, S., Palm, U., Pogarell, O. M., et al. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117223
Küçükaksu, M. H., Hoekstra, T., Vermeulen, J. M., Jansen, L., Helmig, S., van Meijel, B., & Adriaanse, M. C. (2026) · Psychological Medicine · doi:10.1017/s0033291726104516
“Smoking cessation was determined through self-report (i.e. abstinent in the last 7 days) and verified by exhaled CO level lower than 10 parts per million (Benowitz et al., 2020).”
Agterberg, S., Shuter, J., Stanton, C. A., Seng, E. K., & Weinberger, A. H. (2026) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-026-03014-x
Association of Smoking Status and Urinary Cotinine Levels With Lipoprotein(a) in Korean Adults
Kim, B. J., Jang, A. Y., & Kang, J. (2026) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2026.15.2.317
Abdel‐Qader, D. H., Mazrouei, N. A., Taybeh, E. O., Ibrahim, R. M., Albassam, A., Massad, E. M., Saleh, A., Jaradat, S., & Al-Omoush, S. (2026) · Pharmacy · doi:10.3390/pharmacy14030077
“Treatment varied according to the participant’s baseline tobacco-use phenotype [21]: (1) exclusive cigarette users (were primarily directed toward standard NRT or varenicline; (2) xclusive wa-terpipe/shisha users focused heavily on behavioral cue management and (3) dual users were recommended…”
InfluentialNurse-led smoking cessation with cytisinicline in primary care: An intervention study
García, R. M., Villoria, M. G. E., Fernández-Martínez, M. N., Madero, A. D., & Fernández-García, D. (2026) · International Journal of Nursing Studies Advances · doi:10.1016/j.ijnsa.2026.100578
“…of smoking abstinence at 1, 3, and 6 months (self-reported), and at 12 months (self-reported with biochemical verification using exhaled carbon monoxide measurement, with a cut-off point lower than 6 ppm (Benowitz et al., 2020), or urinary cotinine testing), which constituted the primary outcome.”
Parragi, F. K., Vissers, G. C. W. P., Tanis, C. C., & Blanken, T. F. (2026) · Journal of Health Psychology · doi:10.1177/13591053261452202
Money Helps: Financial Incentives for Smoking Cessation Among People Experiencing Homelessness
Gu, D., Cuby, J., Gomez, O., Hawes, M. R., Hall, S., Stitzer, M. L., Kushel, M., & Vijayaraghavan, M. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2682312
Türkiye’de yeni uygulama: Aile sağlığı merkezinde sigara bırakma polikliniğinin ilk sonuçları
Altun, R., & Acar, T. (2026) · Turkish Journal of Tobacco Control · doi:10.64511/tjtc.2026.101
Zhang, R., Long, W., & Li, Y. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/217959
“Tobacco smoke exposure was assessed by measuring serum cotinine, which serves as a proxy for both direct inhalation and passive inhalation of environmental tobacco smoke 11 .”
Alghofaili, F., Hussein, H. M., Najmuldeen, H. H. R., Tahsin, S. Y., Muhamad, A. H., Othman, A. J., Karim, K. F., Ali, A. O., & Karim, A. S. (2026) · FASEB BioAdvances · doi:10.1096/fba.2025-00296
Biomarker of exposure to nicotine-containing products - Saliva
Toolkit, P. (2026) · PhenX Toolkit · doi:10.82568/phenx_toolkit/091708
Biomarker of exposure to nicotine-containing products - Urine
Toolkit, P. (2026) · PhenX Toolkit · doi:10.82568/phenx_toolkit/091707
Biomarker of exposure to nicotine-containing products - Serum
Toolkit, P. (2026) · PhenX Toolkit · doi:10.82568/phenx_toolkit/091709
Toolkit, P. (2026) · PhenX Toolkit · doi:10.82568/phenx_toolkit/720301
Toolkit, P. (2026) · PhenX Toolkit · doi:10.82568/phenx_toolkit/720403
Social desirability and self-reported cigarette smoking among Lebanese adults
Ghostin, M., Gerges, C., Sacre, H., Malhab, S. B., Haddad, C., Hatem, R., Sakr, F., Eid, R., Chkayban, G., Karam, D., et al. (2026) · Discover Public Health · doi:10.1186/s12982-026-02204-6
“Moreover, using innovative or alternative data collection methods such as biomarker validation, indirect questioning, or digital behavior tracking would potentially reduce social desirability bias and help improve assessment accuracy [30].”
Respiratory symptoms and exercise responses among adult E‐cigarette users with and without obesity
Walsh, J. W., Beck, M., Hinton, A., Wagener, T. L., Lang, J. E., Wang, J. G., & Bhammar, D. M. (2026) · Physiological Reports · doi:10.14814/phy2.70993
“However, current smokers were excluded from participation, which was verified by exhaled carbon monoxide (Benowitz et al., 2020).”
Zain, S. M. S. M., Mohamad, N., Anual, Z. F., Shukor, I. H. A., & Azmi, W. N. F. W. (2026) · Tobacco Use Insights · doi:10.1177/1179173x261459432
“22,45 A wide range of urinary cotinine cut-off concentrations was identified across the included studies, reflecting substantial heterogeneity in exposure classification.”
Vevang, K. R., Trinh, A., Schmitt, T. W., Zhao, Y., von Weymarn, L. B., Meier, E. M., Nomura, S. O., Robien, K., Wang, R., Yuan, J.-M., et al. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6c00222
Liang, Y., Zhou, T., Yang, A., Wang, D., Zhang, W., & Gong, W. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/220846
“Among these, serum cotinine concentration serves as an objective and reliable biomarker for assessing exposure to tobacco smoke and associated health risks 14 .”
Micalizzi, L., Sokolovsky, A. W., Murphy, C. M., Knopik, V. S., & Risica, P. M. (2026) · Pediatric Research · doi:10.1038/s41390-026-05238-3
Dowd, A. N., Baker, N. L., Koffarnus, M. N., Raiff, B. R., Tomko, R. L., Gray, K. M., & McClure, E. A. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110992
Liang, Y., Jiang, H., Zhong, Y., Qiu, S., Li, X., & Xie, P. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/3372455 · Cited by 1
“…significant proximal metabolite of nicotine and is regarded as a trustworthy and sensitive indicator of tobacco smoke exposure within the past 72 h [33, 53], and therefore, cotinine has been recognized as a distinctive chemical reflecting an individual's degree of tobacco smoke exposure in recent…”
InfluentialMasonbrink, A. R., Wooten, S., Yeh, H., Stancil, S. L., Miller, M. K., Wilson, K. M., Simon, T. D., Leventhal, A. M., & Catley, D. (2026) · Tobacco Control · doi:10.1136/tc-2025-060006
Trends in the accuracy of self-reported cigarette smoking in Canada
Guindon, G. E., Yu, S. D., & Anderson, L. N. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag172
Hawk, L. W., Schnoll, R. A., Dahne, J., Carpenter, M. J., Cropsey, K. L., Wilding, G. E., Duerr, C., Allen, C. G., Nghiem, V. T., Shelton, R. C., et al. (2026) · Trials · doi:10.1186/s13063-026-09910-1
Xiao, S., Hu, T., Du, C., Bai, L., Dong, K., Guo, W., & Jiang, X. (2026) · BMC Public Health · doi:10.1186/s12889-026-28663-9
“Cotinine, a nicotine metabolite, can signify if an individual is actively smoking or has been exposed to environmental tobacco smoke [14].”
Frisbee, S., Misiewicz, R., Noonan, D., & Lipkus, I. (2026) · Journal of Child & Adolescent Substance Use · doi:10.1080/29973368.2026.2708751
“…be addressed by using more objec-tive measures, such as biochemical verification of nicotine exposure (e.g., cotinine or carbon monoxide testing) (Benowitz et al., 2020; SRNT Subcommittee on Biochemical Verification, 2002) or environmental assessments of secondhand smoke exposure (Office on…”
Jiaheng, S. H. A. O., Huang, C., Chen, X., & Zhao, H. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/224313
“Tobacco smoke is a highly complex aerosol containing over 4000 compounds 26 , and current assessments of tobacco exposure primarily rely on serum cotinine levels, a metabolite of nicotine 27 .”
Contingency Management for Smoking Cessation Among Adults Experiencing Homelessness
Gu, D., Chakravarty, D., Cuby, J., Hall, S., Stitzer, M. L., Kushel, M., Xia, F., & Vijayaraghavan, M. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.27917
Zhou, Y., & Zhu, J. (2026) · Medicine · doi:10.1097/md.0000000000050146
“…included: BMI (kg/m 2 , continuous, computed from measured height/weight); smoking history (life-time consumption ≥ 100 cigarettes, binary) [17] ; alcohol use (≥12 drinks annually, binary) [18] ; hypertension (physician-diagnosed, antihypertensive medication use, or measured BP ≥ 130/80 mm…”
Karelitz, J. L., Rose, J. E., Kennedy, J. N., Freehauf, C., Willette, P. N., Cohen, G. A., Botts, D. R., Botts, T. L., Largo, E. G., Richter, N., et al. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113328
Zahid, R. R., Alif, A. I., Sakib, S. A., Mim, M. A., Tanvir, M. A. H. A., & Hasib, A. (2026) · International Conference on Power, Electronics, Communications, Computing, and Intelligent Infrastructure (PECCII) · doi:10.1109/peccii70991.2026.11661991
“However, conventional methods rely on self-administered questionnaires and are prone to reporting bias, or on biochemical verification which is invasive and lacks scalability [6].”
Kahler, C. W., Cioe, P. A., Hoeppner, B. B., Strowger, M., Nalven, T., Spillane, N. S., Parks, A. C., Bock, B. C., & Brown, R. A. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag196
Liu, X., Jiang, Q., Xie, B., Zhang, Z., Zhou, J., Zhou, T., & Wang, H. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864261483986
Streck, J. M., Regan, S., Chang, Y., Reyen, M., Sterling-Maisel, C., Cannistraro, J., Guerinot, J., Gouda, S., Nahvi, S., Wakeman, S. E., et al. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag205
Akagi, Y., Arakawa, K., Sakima, A., Kabayama, M., Sugimoto, K., Akasaki, Y., Fukami, A., Sakata, S., Ryuno, H., Kadoya, H., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02797-0
Metadata
- Authors
- Benowitz, N. L., Bernert, J. T., Foulds, J., Hecht, S. S., Jacob, P., Jarvis, M. J., Joseph, A., Oncken, C., & Piper, M. E.
- Affiliations
- University of California, San Francisco (US)
- Centers for Disease Control and Prevention (US)
- Pennsylvania State University (US)
- University of Minnesota (US)
- University College London (GB)
- University of Connecticut (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Benowitz, Neal L
- ORCID
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-10-01
- Volume
- 22
- Issue
- 7
- Pages
- 1086-1097
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- PMC
- PMC7882145
- OpenAlex
- W2978389675
- Cited by
- 619
- References
- 121
- Citations by year
- 2026: 99 · 2025: 84 · 2024: 107 · 2023: 103 · 2022: 87 · 2021: 79 · 2020: 54 · 2019: 4
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Nicotine & Tobacco Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- tobacco use, smoking abstinence, biomarkers, cotinine, carbon monoxide, electronic cigarettes, NNAL, biological specimen, detection window
- MeSH terms
- Cigarette Smoking, Carbon Monoxide, Cotinine, Humans, Nicotine, United States, Biomarkers, Smoking Cessation, Tobacco Products
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review